相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Adipose Tissue as an Immunological Organ
Ryan W. Grant et al.
OBESITY (2015)
Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study
Nick Wlazlo et al.
DIABETES CARE (2014)
C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors
Bo Nilsson et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Serum Immunoglobulin M Concentration Is Positively Related to Metabolic Syndrome in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study
Kun Song et al.
PLOS ONE (2014)
Metabolic syndrome: A novel high-risk state for colorectal cancer
Kousuke Ishino et al.
CANCER LETTERS (2013)
Endogenous sex hormones and C-reactive protein in healthy chinese men
Youjie Zhang et al.
CLINICAL ENDOCRINOLOGY (2013)
C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling
Junxian Lim et al.
FASEB JOURNAL (2013)
The Complement Anaphylatoxin C5a Receptor Contributes to Obese Adipose Tissue Inflammation and Insulin Resistance
Julia Phieler et al.
JOURNAL OF IMMUNOLOGY (2013)
The role of the complement system in metabolic organs and metabolic diseases
Julia Phieler et al.
SEMINARS IN IMMUNOLOGY (2013)
Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice
Xueli Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk
Catherine M. Phillips et al.
ATHEROSCLEROSIS (2012)
Inflammatory Mechanisms in Obesity
Margaret F. Gregor et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
The Association of Smoking and Erectile Dysfunction: Results From the Fangchenggang Area Male Health and Examination Survey (FAMHES)
Chunlei Wu et al.
JOURNAL OF ANDROLOGY (2011)
Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey
Aihua Tan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Associations of inflammatory markers with coronary artery calcification: Results from the Multi-Ethnic Study of Atherosclerosis
Nancy Swords Jenny et al.
ATHEROSCLEROSIS (2010)
Inflammation and the Incidence of Type 2 Diabetes The Multi-Ethnic Study of Atherosclerosis (MESA)
Alain G. Bertoni et al.
DIABETES CARE (2010)
The metabolic syndrome
Robert H. Eckel et al.
LANCET (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population
Altan Onat et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome
Catherine M. Phillips et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Low-grade inflammation and the metabolic syndrome in children and adolescents
Julia Wärnberg et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
C-Reactive Protein and 5-Year Survival in Type 2 Diabetes The Casale Monferrato Study
Graziella Bruno et al.
DIABETES (2009)
Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults
B. Puchau et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2009)
Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents
Ponce Cedric Fouejeu Wamba et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women
Howard D. Sesso et al.
HYPERTENSION (2007)
The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers
Antonie J. H. H. M. van Oostrom et al.
ATHEROSCLEROSIS (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes - Synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor
Y Aso et al.
DIABETES CARE (2005)
Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children
K Cianflone et al.
CLINICAL ENDOCRINOLOGY (2005)
Cross-sectional study of complement C3 as a coronary risk factor among men and women
A Onat et al.
CLINICAL SCIENCE (2005)
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study
AM McNeill et al.
DIABETES CARE (2005)
Complement C3 is a risk factor for the development of diabetes -: A population-based cohort study
G Engström et al.
DIABETES (2005)
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
MP Stern et al.
DIABETES CARE (2004)
Inflammation: the link between insulin resistance, obesity and diabetes
P Dandona et al.
TRENDS IN IMMUNOLOGY (2004)
C-reactive protein and the risk of developing hypertension
HD Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Acylation stimulating protein stimulates insulin secretion
B Ahrén et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Low-grade systemic inflammation and the development of type 2 diabetes - The atherosclerosis risk in communities study
BB Duncan et al.
DIABETES (2003)
High expression of complement components in omental adipose tissue in obese men
BG Gabrielsson et al.
OBESITY RESEARCH (2003)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Phylogenetic aspects of the complement system
IK Zarkadis et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2001)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)